(Featured Image: Toho / Toei Company / Khara)
Japanese midnight screenings of Evangelion: 3.0+1.0 Thrice Upon a Time have been canceled due to concerns about the spread of COVID-19. Announced on the official Japanese site alongside a message of thanks to healthcare workers and sympathies to victims of this devastating pandemic.
“First of all, I would like to express my deepest sympathies to all the victims of the new coronavirus infection (COVID-19).Evangelion.co.jp
We would also like to express our gratitude and respect to the medical professionals and their stakeholders who are still responding.
Due to the spread of the new coronavirus infection and the shortening of business hours of some movie theaters due to the announcement of the state of emergency, January 23 (Sat) 0:00 (= January 22 (Fri)) ) We have decided to cancel the world’s fastest screening of “Shin Evangelion Theatrical Version” scheduled from 24:00).
Therefore, the scheduled ticket handling from 0:00 on January 13 (Wednesday) will also be cancelled.
We deeply apologize to everyone who looked forward to it.
In addition, regarding this matter, we will individually inform the winners of the invitation project in the future, so please wait for appropriate contact.
We apologize for the inconvenience, and thank you for your continued support.”
Evangelion: 3.0+1.0 Thrice Upon a Time is the long-awaited fourth and final film in Evangelion’s Rebuild film series. It was announced alongside Evangelion: 3.0 You Can (Not) Redo and was expected to release in 2015 but was delayed until June 2020 before being further delayed due to the COVID-19 pandemic. The film’s current release date is set for January 23, with special midnight screenings canceled.
The cancellation comes in response to Japan’s applying strict regulations following a recent rise in COVID-19 cases, shortening business operating hours, and occupation limits.
Evangelion: 3.0+1.0 Thrice Upon a Time will release in Japanese theaters on January 23rd. No word at the time of writing on Western releases or screenings.